‘Three distinct genomic landscapes define clinical outcome of pancreatic neuroendocrine tumours (pNETs)’

NETwork’s Dr Ben Lawrence proposed a model for grouping pancreatic NETs according to clinicogenomic findings at the AGIGT 19th Annual Scientific Meeting this month.  The findings from our genomic profiling of a series of 69 pancreatic NETs lead to the discovery of three groups, and clinical outcomes could potentially be predicted from genomic studies according to this early investigative model.

Click here to view the poster.